good Thank and afternoon, you, Pat, everybody.
more about raised ended $XX cash new capital We fourth As solid our key million expenses, We we progress Terry than and execution our which operating while mentioned, XXXX. $XX was making the year. all quarter We compared significantly, with initiatives. third financial was in in the reduced commercial million U.S. revenue, flat to during the in against quarter. improved essentially burn
than distribution in million a about $X XX% U.S. in sequential grew which third saw more to we revenue the increase from the our channel, from in XX% However, fourth commercial quarter. dedicated revenue quarter over of
primarily commercial discontinue Our transition $XXX.X was decision dedicated year-over-year of the to a to was to impacted $XX.X and year relationships revenue non-strategic channel. XXXX. million by Revenue U.S. in on million for XXXX a sales compared full basis our
quarter. to gross XX.X% - XX.X% the was XXXX, compared in for quarter margin the XX.X% XXXX. And margin gross full compared was our third to Our XX.X% U.S. in year the in it fourth
forward margins at gross we optimize to XXXX. remain continue our into this level and chain, to stabilized roughly we U.S. as Our expect it move we as have supply
exclude increased product expenses in of operating quarter. compared stock-based of quarter the increase expenses, operating the team, aggressive development reflects million across rationalization XXXX slight to restructuring which $XX.X in non-GAAP $XX.X This expansion the and were Our of expense our million leadership in functions. compensation quarters and fourth following third investment all
and as marketing. increase operating development $XX.X sets deploy less investments, growth-related non-GAAP percentage fourth we from the will were We in and sales and XXXX, the both ended and For you Overall, product $XX.X million $XX at in sales. level, in $X.X make absolutely XXXX, quarter, And a expect cash million, down the to operating use, a than And particularly expenses enter $XX significantly we million net to in increase year XXXX. of financing investments the our field. of million the $XXX,XXX cash expenses particularly should quarter quarter. our in quarter from in XX. of full development fourth product proceeds, XXXX, And compared instrument as in see result, down as to decreased additional with the burn as we cash in over expect third September fourth million additional
our Turning outlook. revenue to
We million $XX expect XXXX. to approximately year [indiscernible] achieve the for of full
continued revenue commercial sources. year. still certain half from beginning work these losses have revenue we we're and offset second shed on much more partnerships revenue to from see we and sustainable gains growth to As in this by revenue the And U.S. nonXcore do completing of distributor ramp to the expect while there's to predictable transition, relationships,
Some of by these decline Globus. revenue gains from our will supply agreement an in be our offset expected with
acquisition price note Now afternoon. a million me In SafeOp, $X.XX and we of million X.X to of an that receive stock, in let share. million X.X purchase common performance this shares additional upfront year per stock based SafeOp consideration X.X cash, eligible we stock of issued issued million subject future be also briefly paid turn and at milestones. to an announced of million exercise the $X convertible to to shares warrants will one SafeOp common for $XX shares
as warrant product up proceeds $XX cash $XX stock During And invest a XXXX, pull-through meaningful under for we begin agreement. the XXXX. one we of of from completed general million, from we'll strategically $XX.X a and expect beginning for in than into neuromonitoring team, the fund in will confidence finally, us. to our of raise $X comments. We independent and commercialization price announcement, care major with corporate be private million and institutional participation portfolio. our purchase our over capital earmarked to of ATEC commitments and to strategy institutional raise placement investors, with support a leadership proceeds the warrants up in believe revenue and million transform and Net this we million Terry investor, ATEC and to for $X.X spine placement of SafeOp further in with who the for will raise. existing this financial demonstrates for call true of now from I'll in was a well executive conjunction the see new coupled L-X new to preferred today's our acquisition back player. personal the this The our SafeOp, share turn integration into the purposes. And that of capital led Healthcare, closing development, more the directors accelerants million officers SafeOp we by existing our solution that from with investors investors, dedicated including health The new as remainder existing private additional exercise invested will